1. Home
  2. GOVX vs OLB Comparison

GOVX vs OLB Comparison

Compare GOVX & OLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$0.83

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Logo The OLB Group Inc.

OLB

The OLB Group Inc.

HOLD

Current Price

$0.31

Market Cap

4.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOVX
OLB
Founded
2001
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
4.5M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
GOVX
OLB
Price
$0.83
$0.31
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
196.2K
187.4K
Earning Date
04-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
71.48
EPS
N/A
N/A
Revenue
$2,489,145.00
$8,676,907.00
Revenue This Year
N/A
$12.19
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.27
52 Week High
$4.40
$1.80

Technical Indicators

Market Signals
Indicator
GOVX
OLB
Relative Strength Index (RSI) 43.96 40.91
Support Level $0.64 $0.27
Resistance Level $2.00 $0.34
Average True Range (ATR) 0.09 0.03
MACD 0.03 0.00
Stochastic Oscillator 56.54 34.70

Price Performance

Historical Comparison
GOVX
OLB

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified FinTech company that focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. The company seeks to provide merchants with a wide range-of-products and services through the various online platforms, including financial and transaction processing services. It also has products that provide support for crowdfunding and other capital-raising initiatives. It supplements the online platforms with certain hardware solutions that are integrated with the online platforms. The company has two business segments: Fintech Services, which generates key revenue, and the Bitcoin Mining business segment.

Share on Social Networks: